Reduction of unwanted submental fat with ATX ‐101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III , randomized, placebo‐controlled study-Reference-Cited by-同舟云学术

Reduction of unwanted submental fat with ATX ‐101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III , randomized, placebo‐controlled study

Published:2014-02 Issue:2 Volume:170 Page:445-453
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Rzany B.¹,Griffiths T.²,Walker P.³,Lippert S.⁴,McDiarmid J.⁵,Havlickova B.⁴

Affiliation:

1. Division of Evidence‐Based Medicine in Dermatology Charité‐Universitätsmedizin, and RZANY & HUND Privatpraxis und klinisches Studienzentrum für Dermatologie Berlin Germany

2. Salford Royal NHS Foundation Trust and Dermatopharmacology Unit Faculty of Medical and Human Sciences Manchester Academic Health Science Centre The University of Manchester Manchester U.K

3. KYTHERA Biopharmaceuticals, Inc. Calabasas CA U.S.A

4. Global Clinical Development Dermatology Bayer HealthCare Berlin Germany

5. McDiarmid‐Hall Clinic Derriford Plymouth U.K

Funder

Bayer HealthCare

KYTHERA Biopharmaceuticals, Inc.

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.12695